On August 13, dietary supplement developer “Tanba Pharma” completed a 10 million RMB angel round of financing, led by Hong Kong Guihe Capital. Tanba Pharma, a subsidiary of the Japanese health food company Showa Co., Ltd., is a developer and producer of dietary supplements. The company has successfully operated several trusted health food brands in Greater China, including “Tanba Kanrai,” “Azuchi Momoyama,” and “Kohakuho.” Their product line covers popular health categories such as glucosamine, high-concentration fish oil, coenzyme Q10, oyster extract, resveratrol, ergothioneine, and royal jelly. Source: FromGeek.com
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE